loadpatents
name:-0.026633024215698
name:-0.014464139938354
name:-0.0009760856628418
Liao; Shutsung Patent Filings

Liao; Shutsung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liao; Shutsung.The latest application filed is for "method of treating disorder related to high cholesteral concentration".

Company Profile
0.12.18
  • Liao; Shutsung - Chicago IL
  • Liao, Shutsung - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Liver X receptor agonists
Grant 8,829,213 - Peng , et al. September 9, 2
2014-09-09
Method Of Treating Disorder Related To High Cholesteral Concentration
App 20140088060 - Song; Ching ;   et al.
2014-03-27
Method Of Treating Disorder Related To High Cholesterol Concentration
App 20130210792 - Song; Ching ;   et al.
2013-08-15
Method Of Treating Disorder Related To High Cholesterol Concentration
App 20110160174 - Song; Ching ;   et al.
2011-06-30
Liver X Receptor Agonists
App 20110059932 - Peng; Dacheng ;   et al.
2011-03-10
Method Of Treating Disorder Related To High Cholesterol Concentration
App 20100093687 - Song; Ching ;   et al.
2010-04-15
Method of treating disorder related to high cholesterol concentration
App 20070197484 - Song; Ching ;   et al.
2007-08-23
Methods of treating cancers
App 20070032464 - Liao; Shutsung ;   et al.
2007-02-08
Method of treating disorder related to high cholesterol concentration
Grant 7,078,396 - Song , et al. July 18, 2
2006-07-18
Liver X receptor agonists
Grant 7,012,069 - Song , et al. March 14, 2
2006-03-14
Steroid derivatives
App 20060025393 - Liao; Shutsung ;   et al.
2006-02-02
Polyhydroxylated benzene-containing compounds
App 20050113426 - Liao, Shutsung ;   et al.
2005-05-26
Steroid derivatives
App 20040152681 - Liao, Shutsung ;   et al.
2004-08-05
Method and compositions for regulation of 5-alpha reductase activity
Grant 6,696,484 - Liao , et al. February 24, 2
2004-02-24
Farnesoid X-activated receptor agonists
App 20040014734 - Song, Ching ;   et al.
2004-01-22
3,6-dihydroxy-24-amidyl steroid derivatives
Grant 6,645,955 - Liao , et al. November 11, 2
2003-11-11
Polyhydroxylated benzene-containing compounds
Grant 6,610,749 - Liao , et al. August 26, 2
2003-08-26
Novel anticholesterol compositions and method for using same
App 20030153541 - Dudley, Robert ;   et al.
2003-08-14
Methods and compositions for regulation of 5-alpha reductase activity
App 20030144346 - Liao, Shutsung ;   et al.
2003-07-31
Polyhydroxylated benzene-containing compounds
App 20030139477 - Liao, Shutsung ;   et al.
2003-07-24
Method of treating disorder related to high cholesterol concentration
App 20030139385 - Song, Ching ;   et al.
2003-07-24
Methods and compositions for regulation of 5-.alpha.-reductase activity
Grant 6,576,660 - Liao , et al. June 10, 2
2003-06-10
Method and compositions for regulation of 5-alpha reductase activity
App 20030105030 - Liao, Shutsung ;   et al.
2003-06-05
Liver X receptor agonists
App 20020193357 - Song, Ching ;   et al.
2002-12-19
Steriodal derivatives
App 20020107233 - Liao, Shutsung ;   et al.
2002-08-08
Isolated nucleic acid encoding a ubiquitous nuclear receptor
Grant 5,639,616 - Liao , et al. June 17, 1
1997-06-17
DNA binding proteins including androgen receptor
Grant 5,614,620 - Liao , et al. March 25, 1
1997-03-25
Methods and compositions for inhibiting 5.alpha.-reductase activity
Grant 5,605,929 - Liao , et al. February 25, 1
1997-02-25
Anti-androgen compounds
Grant 5,480,913 - Liao , et al. January 2, 1
1996-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed